Ajooni Biotech logo

Ajooni Biotech

AJOONI NSE

Key Fundamentals

MicrocapFood - Processing - IndianFMCG
Market Cap
₹59.42 Cr
Volatility
Moderate
P/E Ratio
15.09
EBITDA
₹6.26 Cr
Return on Equity
3.83%
Debt to Equity
0.2
Book Value
₹5.29
52W High
₹5.94
52W Low
₹3.4

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Stock is trading at 0.66 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 48.8 to 35.7 days.
  • Company's working capital requirements have reduced from 129 days to 93.5 days

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 30.5%
  • Company has a low return on equity of 4.99% over last 3 years.

Growth Rate

Revenue Growth
56.15% higher than 3Y
Net Income Growth
23.82% lower than 3Y
Cash Flow Change
-177% higher than 3Y
ROE
-24.31% lower than 3Y
ROCE
-35.21% lower than 3Y
EBITDA Margin (Avg.)
-31.24% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
21
19.48
20.05
19.58
25.66
25.72
34.03
29.27
31.27
31.74
58.75
60.62
63.49
Expenses
20.34
18.85
20.7
17.99
24.7
24.95
33.1
28.26
30.56
30.24
55.72
59.61
61.82
Operating Profit
0.66
0.63
-0.65
1.59
0.96
0.77
0.93
1.01
0.71
1.5
3.03
1.01
1.67
OPM %
3.14%
3.23%
-3.24%
8.12%
3.74%
2.99%
2.73%
3.45%
2.27%
4.73%
5.16%
1.67%
2.63%
Other Income
0.07
0.29
1.57
0.26
0.04
0.31
0.39
1.34
0.65
0.15
0.32
1.3
0.27
Interest
0.13
0.19
0.12
0.11
0.15
0.06
0.07
0.06
0.08
0.17
0.18
0.29
0.48
Depreciation
0.21
0.21
0.21
0.24
0.22
0.23
0.24
0.38
0.25
0.25
0.81
0.9
0.8
PBT
0.39
0.52
0.59
1.5
0.63
0.79
1.01
1.91
1.03
1.23
2.36
1.12
0.66
Tax %
-2.56%
23.08%
23.73%
38.67%
25.4%
22.78%
27.72%
19.37%
24.27%
24.39%
30.08%
15.18%
34.85%
Net Profit
0.4
0.4
0.44
0.91
0.47
0.62
0.73
1.54
0.78
0.93
1.65
0.95
0.43
EPS in Rs
0.02
0.02
0.03
0.05
0.03
0.04
0.04
0.09
0.05
0.05
0.1
0.06
0.02
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7
13
29
42
40
40
51
74
74
80
115
182
215
Expenses
7
13
28
41
39
39
49
71
72
78
111
176
207
Operating Profit
0
0
1
1
1
1
2
3
3
2
4
6
7
OPM %
1.8%
1.7%
2.4%
2.2%
1.7%
3.1%
3.2%
4.2%
3.7%
2.8%
3.2%
3.4%
3.4%
Other Income
0
0
0
0
0
0
0
0
0
2
2
2
2
Interest
0
0
0
0
0
0
1
1
0
1
0
1
1
Depreciation
0
0
0
0
0
0
1
1
1
1
1
2
3
PBT
0
0
0
0
0
0
0
1
2
3
4
6
5
Tax %
27%
29%
28%
20%
15%
29%
26%
28%
28%
28%
22%
25%
—
Net Profit
0
0
0
0
0
0
0
1
1
2
3
4
4
EPS in Rs
0.12
0.18
0.36
0.03
0.03
0.02
0.02
0.05
0.06
0.12
0.2
0.25
0.23
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.24
0.24
0.33
6
6
8
10
10
18
18
34
34
Reserves
0
0
1
5
6
7
6
6
24
25
54
57
Borrowings
0
1
1
5
5
5
7
5
5
2
2
18
Other Liabilities
1
1
11
4
1
2
6
7
12
3
5
11
Total Liabilities
2
2
13
19
18
23
28
29
59
48
95
120
Fixed Assets
0
0
1
1
1
2
5
6
6
10
11
26
CWIP
0
0
0
0
0
0
0
0
0
1
0
0
Investments
0
0
6
6
4
3
1
1
4
2
3
2
Other Assets
1
2
6
12
13
18
22
22
48
34
80
92
Total Assets
2
2
13
19
18
23
28
29
59
48
95
120
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
-1
-3
-3
-5
-4
1
4
-6
23
-18
-6
Investing
0
0
-2
0
1
0
-3
-2
-16
8
-17
-16
Financing
0
1
5
8
-1
3
2
-2
22
-4
25
15
Net Cash Flow
0
0
0
5
-5
-1
0
0
0
27
-10
-6
Free Cash Flow
0
-1
-3
-3
-5
-6
-2
2
-8
17
-19
-23
CFO/OP
169
-257
-427
-284
-706
-353
71
125
-185
1,047
-458
-92
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
40
33
17
25
44
115
98
68
101
59
52
36
Inventory Days
22
14
63
19
51
34
46
34
39
80
90
97
Days Payable
66
27
79
9
12
20
46
39
56
8
13
22
Cash Conversion Cycle
-4
20
1
35
84
129
98
63
83
131
129
111
Working Capital Days
5
9
-29
-1
84
105
77
58
94
132
160
93
ROCE %
28%
18%
37%
10%
4%
4%
5%
9%
6%
8%
7%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ajooni Biotech insights

59 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

Public65.76%Others7.35%Promot.26.89%As ofJun 2026

Documents

1
Concall - Jan 2025 Jan 2025
2
Concall - Oct 2024 Oct 2024
3
Concall - May 2024 May 2024
4
Concall - May 2024 May 2024
5
Concall - Jun 2022 Jun 2022

Frequently Asked Questions about Ajooni Biotech

What does Ajooni Biotech Ltd do?
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.[1]
Where is Ajooni Biotech Ltd (AJOONI) listed?
Ajooni Biotech Ltd trades as AJOONI on the NSE.
Which sector does Ajooni Biotech Ltd belong to?
Ajooni Biotech Ltd is classified under the FMCG sector, in the Food - Processing - Indian industry.
What is the market capitalisation of Ajooni Biotech Ltd?
Ajooni Biotech Ltd has a market capitalisation of ₹59.42 Cr, which places it in the Small Cap band.
What is the PE ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd trades at a PE ratio of 15.09, against a book value of ₹5.29 per share.
What is the 52-week high and low of Ajooni Biotech Ltd?
Over the last 52 weeks Ajooni Biotech Ltd has traded between ₹3.4 and ₹5.94.
What is the Return on Equity (ROE) of Ajooni Biotech Ltd?
Ajooni Biotech Ltd reported a return on equity of 3.83%. Its debt-to-equity ratio is 0.20.

Company Information

Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.[1]

Website ajoonibiotech.com
CEO Mr. Jasjot Singh
Employees 134
Listed 2018-01-02
Face Value ₹ 2
Issued Size 17,22,43,598

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AJOONI.md for Ajooni Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in FMCG → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List